Viewing Study NCT03532295


Ignite Creation Date: 2025-12-24 @ 2:16 PM
Ignite Modification Date: 2026-01-05 @ 5:20 PM
Study NCT ID: NCT03532295
Status: COMPLETED
Last Update Posted: 2025-11-21
First Post: 2018-05-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas
Sponsor:
Organization: